Eda-Dex administration potently attenuated cerebral damage, protected neurological function, attenuated anxiety-like behavior and improved cognitive function by synergistically inhibiting oxidative stress and inflammation through targeting of the NRF2/ARE and NF-κB/AIM2 pathways in CIRI rats (Figure 9). This evidence concerns the gene AIM2 and Anxiety.